ISIN | LU2814038779 |
---|---|
Valor Number | 134920650 |
Bloomberg Global ID | |
Fund Name | DNB Fund-Biotechnology Retail A (N) CHF |
Fund Provider |
DNB Asset Management AS
Stockholm, Sweden Phone: +46 8 473 41 00 Web: www.cim.se |
Fund Provider | DNB Asset Management AS |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) | |
Asset Class | Other Funds |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | |
Peculiarities |
Current Price * | 98.11 CHF | 27.03.2025 |
---|---|---|
Previous Price * | 97.74 CHF | 26.03.2025 |
52 Week High * | 110.32 CHF | 05.02.2025 |
52 Week Low * | 97.74 CHF | 26.03.2025 |
NAV * | 98.11 CHF | 27.03.2025 |
Issue Price * | 98.11 CHF | 27.03.2025 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | ||
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | -5.41% |
31.12.2024 - 27.03.2025
31.12.2024 27.03.2025 |
---|---|---|
1 month | -5.86% |
27.02.2025 - 27.03.2025
27.02.2025 27.03.2025 |
3 months | -5.89% |
27.12.2024 - 27.03.2025
27.12.2024 27.03.2025 |
6 months | -3.01% |
27.09.2024 - 27.03.2025
27.09.2024 27.03.2025 |
1 year | -8.27% |
19.07.2024 - 27.03.2025
19.07.2024 27.03.2025 |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
No top holdings available for this fund |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** |